This site is intended for healthcare professionals only
LoginRegister
Bayer Nubeqa gets EU approvalBayer Gets CDSCO Panel Nod To Conduct Phase 3 Trial for Finerenone
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancerMerck, Daiichi Sankyo withdraw US appication for patritumab deruxtecan for advanced or metastatic...
Sun Pharma Gets SEC Nod to Conduct Phase III Trial of Resmetirom TabletsSun Pharma concludes acquisition of Checkpoint Therapeutics
Cipla Bommasandra facility gets VAI classification from USFDAUSFDA issues one observation for Cipla Bommasandra facility
Dr Reddys Secures CDSCO Panel Approval to Import, Market Olutasidenib for AMLDr Reddy's Gets SEC Nod for Higher Semaglutide Dose in Ongoing Phase III Study, Govt Sites Mandated
Sanofi earns orphan drug designation for multiple myeloma drugCDSCO Panel Clears Sanofi's Updated Myozyme Insert, Seeks Revision on Administration Guidance
Fatal Crash Claims Life of Karauli DoctorExam day turns tragic: BPharm student stabbed to death over relationship
medicineUnauthorized manufacturing of certain veterinary drugs at pharma unit, stock worth Rs 3 lakhs seized
Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug MacitentanAlembic Pharma bags USFDA okay for blood cancer drug Bosutinib
Sun Pharma Sets Record with Over 1 Lakh Uric Acid Screenings in 3 DaysSun Pharma Sets Record with Over 1 Lakh Uric Acid Screenings in 3 Days
AstraZeneca, Summit in discussions over USD 15 billion cancer drug licensing deal: ReportAstraZeneca gets CDSCO nod for new indications of Benralizumab, Osimertinib in India
CDSCO Committee Recommends SpinoS to Conduct BE Study with Vitamin D Screening ConditionsCDSCO Committee Recommends SpinoS to Conduct BE Study with Vitamin D Screening Conditions
X